一名镰状细胞病患者出现羟基脲诱发的皮肤溃疡。 - Suppr

Suppr

超能文献

Hydroxyurea-Induced Cutaneous Ulcers in a Sickle Cell Disease Patient.

作者信息

Dudhe Mayur S, Singh Ajeet, Ganguly Satyaki, Singh Chandan

机构信息

Department of Dermatology, Venereology and Leprosy, Data Meghe Medical College, Nagpur, Maharashtra, India.

Department of Dermatology and Venereology, World College of Medical Sciences and Research, Jhajjar, Haryana, India.

出版信息

Indian Dermatol Online J. 2023 Nov 7;15(3):521-522. doi: 10.4103/idoj.idoj_257_23. eCollection 2024 May-Jun.

DOI:10.4103/idoj.idoj_257_23

PMID:38845647

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11152474/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad46/11152474/87d72e2ce57b/IDOJ-15-521-g001.jpg

相似文献

Hydroxyurea-Induced Cutaneous Ulcers in a Sickle Cell Disease Patient.

Indian Dermatol Online J. 2023 Nov 7;15(3):521-522. doi: 10.4103/idoj.idoj_257_23. eCollection 2024 May-Jun.

Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.

Arch Dermatol. 2001 Apr;137(4):467-70.

Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease.

Ann Hematol. 2022 Mar;101(3):541-548. doi: 10.1007/s00277-021-04635-4. Epub 2022 Jan 18.

Cutaneous ulcers associated with hydroxyurea therapy.

J Tissue Viability. 2013 Nov;22(4):112-21. doi: 10.1016/j.jtv.2013.08.002. Epub 2013 Aug 28.

Cutaneous manifestations of sickle cell disease: an updated review.

Arch Dermatol Res. 2023 May;315(4):729-734. doi: 10.1007/s00403-022-02466-5. Epub 2022 Nov 22.

Sickle cell disease induces resistance to cutaneous carcinogenesis.

Orphanet J Rare Dis. 2020 Mar 6;15(1):66. doi: 10.1186/s13023-020-1341-9.

Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. French Study Group on Sickle Cell Disease.

Arch Dis Child. 1999 Nov;81(5):437-9. doi: 10.1136/adc.81.5.437.

Oxidative stress, inflammation, blood rheology, and microcirculation in adults with sickle cell disease: Effects of hydroxyurea treatment and impact of sickle cell syndrome.

Eur J Haematol. 2021 Jun;106(6):800-807. doi: 10.1111/ejh.13607. Epub 2021 Mar 30.

Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia.

Pediatr Dermatol. 2004 Nov-Dec;21(6):633-5. doi: 10.1111/j.0736-8046.2004.21603.x.

Does hydroxyurea prevent pulmonary complications of sickle cell disease?

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):432-7. doi: 10.1182/asheducation-2014.1.432. Epub 2014 Nov 18.

本文引用的文献

Hydroxyurea-The Good, the Bad and the Ugly.

Genes (Basel). 2021 Jul 19;12(7):1096. doi: 10.3390/genes12071096.

Leg ulcers in sickle cell disease.

Am J Hematol. 2010 Oct;85(10):831-3. doi: 10.1002/ajh.21838.

A Hydroxyurea-induced Leg Ulcer.

Ann Dermatol. 2009 Feb;21(1):39-41. doi: 10.5021/ad.2009.21.1.39. Epub 2009 Feb 28.

Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

Ann Intern Med. 2008 Jun 17;148(12):939-55. doi: 10.7326/0003-4819-148-12-200806170-00221. Epub 2008 May 5.

Hydroxyurea associated leg ulcer succesfully treated with hyperbaric oxygen in a diabetic patient.

Exp Clin Endocrinol Diabetes. 2007 Feb;115(2):143-5. doi: 10.1055/s-2007-956164.

Leg ulcer in a patient associated with hydroxyurea therapy.

Int J Dermatol. 2006 Feb;45(2):158-60. doi: 10.1111/j.1365-4632.2004.02450.x.

Successful healing of hydroxyurea-related leg ulcers with topical granulocyte-macrophage colony-stimulating factor.

Blood. 1999 Aug 15;94(4):1479-80.

Leg ulcer associated with hydroxyurea treatment in a patient with chronic myelogenous leukaemia: successful treatment with prostagladin E1 and pentoxifylline.

Br J Dermatol. 1998 Dec;139(6):1124-6. doi: 10.1046/j.1365-2133.1998.2576l.x.

Vasculitic leg ulcers in chronic myelogenous leukemia.

Am J Med. 1985 May;78(5):869-72. doi: 10.1016/0002-9343(85)90297-9.

Skin changes secondary to hydroxyurea therapy.

Arch Dermatol. 1975 Feb;111(2):183-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Hydroxyurea-Induced Cutaneous Ulcers in a Sickle Cell Disease Patient.

Indian Dermatol Online J. 2023 Nov 7;15(3):521-522. doi: 10.4103/idoj.idoj_257_23. eCollection 2024 May-Jun.

Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.

Arch Dermatol. 2001 Apr;137(4):467-70.

Hydroxyurea and fetal hemoglobin effect on leg ulcers in patients with sickle cell disease.

Ann Hematol. 2022 Mar;101(3):541-548. doi: 10.1007/s00277-021-04635-4. Epub 2022 Jan 18.

Cutaneous ulcers associated with hydroxyurea therapy.

J Tissue Viability. 2013 Nov;22(4):112-21. doi: 10.1016/j.jtv.2013.08.002. Epub 2013 Aug 28.

Cutaneous manifestations of sickle cell disease: an updated review.

Arch Dermatol Res. 2023 May;315(4):729-734. doi: 10.1007/s00403-022-02466-5. Epub 2022 Nov 22.

Sickle cell disease induces resistance to cutaneous carcinogenesis.

Orphanet J Rare Dis. 2020 Mar 6;15(1):66. doi: 10.1186/s13023-020-1341-9.

Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. French Study Group on Sickle Cell Disease.

Arch Dis Child. 1999 Nov;81(5):437-9. doi: 10.1136/adc.81.5.437.

Oxidative stress, inflammation, blood rheology, and microcirculation in adults with sickle cell disease: Effects of hydroxyurea treatment and impact of sickle cell syndrome.

Eur J Haematol. 2021 Jun;106(6):800-807. doi: 10.1111/ejh.13607. Epub 2021 Mar 30.

Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia.

Pediatr Dermatol. 2004 Nov-Dec;21(6):633-5. doi: 10.1111/j.0736-8046.2004.21603.x.

Does hydroxyurea prevent pulmonary complications of sickle cell disease?

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):432-7. doi: 10.1182/asheducation-2014.1.432. Epub 2014 Nov 18.

本文引用的文献

Hydroxyurea-The Good, the Bad and the Ugly.

Genes (Basel). 2021 Jul 19;12(7):1096. doi: 10.3390/genes12071096.

Leg ulcers in sickle cell disease.

Am J Hematol. 2010 Oct;85(10):831-3. doi: 10.1002/ajh.21838.

A Hydroxyurea-induced Leg Ulcer.

Ann Dermatol. 2009 Feb;21(1):39-41. doi: 10.5021/ad.2009.21.1.39. Epub 2009 Feb 28.

Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

Ann Intern Med. 2008 Jun 17;148(12):939-55. doi: 10.7326/0003-4819-148-12-200806170-00221. Epub 2008 May 5.

Hydroxyurea associated leg ulcer succesfully treated with hyperbaric oxygen in a diabetic patient.

Exp Clin Endocrinol Diabetes. 2007 Feb;115(2):143-5. doi: 10.1055/s-2007-956164.

Leg ulcer in a patient associated with hydroxyurea therapy.

Int J Dermatol. 2006 Feb;45(2):158-60. doi: 10.1111/j.1365-4632.2004.02450.x.

Successful healing of hydroxyurea-related leg ulcers with topical granulocyte-macrophage colony-stimulating factor.

Blood. 1999 Aug 15;94(4):1479-80.

Leg ulcer associated with hydroxyurea treatment in a patient with chronic myelogenous leukaemia: successful treatment with prostagladin E1 and pentoxifylline.

Br J Dermatol. 1998 Dec;139(6):1124-6. doi: 10.1046/j.1365-2133.1998.2576l.x.

Vasculitic leg ulcers in chronic myelogenous leukemia.

Am J Med. 1985 May;78(5):869-72. doi: 10.1016/0002-9343(85)90297-9.

Skin changes secondary to hydroxyurea therapy.

Arch Dermatol. 1975 Feb;111(2):183-7.